Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Otherwise Healthy Overweight or Obese”

34 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 34 results

Early research (Phase 1)Study completedNCT03775278
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of Multiple-Ascending Doses of PHP-303 in Otherwise Healthy Overweight or Obese Subjects

Who this might be right for
Otherwise Healthy Overweight or Obese
pH Pharma 50
Early research (Phase 1)Active Not RecruitingNCT07499050
What this trial is testing

Multiple Doses of Orally Administered RO7795081 in Otherwise Healthy Chinese Adult Participants With Obesity or Overweight

Who this might be right for
Healthy VolunteersOverweight or Obesity
Hoffmann-La Roche 30
Early research (Phase 1)Study completedNCT01146327
What this trial is testing

A Multiple Dose Study Of PF-04620110 In Healthy Overweight Or Obese Subjects

Who this might be right for
Healthy
Pfizer 60
Early research (Phase 1)Study completedNCT04903509
What this trial is testing

A Study in Men With Overweight to Test How Well Different Doses of BI 1820237 Are Tolerated When Given as an Injection Alone or in Combination With Liraglutide

Who this might be right for
Healthy
Boehringer Ingelheim 95
Not applicableStudy completedNCT05963594
What this trial is testing

To Evaluate the Post-Prandial Metabolic Effects of Oligomalt in Adults With T2D and in HAO

Who this might be right for
Dietary Supplement
Société des Produits Nestlé (SPN) 44
Early research (Phase 1)Study completedNCT06567327
What this trial is testing

Learn How the Study Medicine Danuglipron is Taken Up Into the Blood and If Danuglipron Changes How the Body Processes Other Study Medicines (Atorvastatin and Rosuvastatin) in Healthy Adults Who Are Overweight or Obese

Who this might be right for
Obesity
Pfizer 82
Early research (Phase 1)Study completedNCT06568731
What this trial is testing

Learn How Different Amounts of the Study Medicine Danuglipron Are Taken up Into the Blood in Otherwise Healthy Adults With Overweight or Obesity

Who this might be right for
Obesity
Pfizer 23
Early research (Phase 1)Study completedNCT06440980
What this trial is testing

Compare Tablets and Capsules of Orforglipron (LY3502970) in Healthy Participants Who Are Obese or Overweight

Who this might be right for
HealthyObeseOverweight+1 more
Eli Lilly and Company 533
Early research (Phase 1)Active Not RecruitingNCT07223216
What this trial is testing

Study of BMF-650 in Otherwise Healthy Overweight or Obese Adult Participants

Who this might be right for
Obesity
Biomea Fusion Inc. 80
Early research (Phase 1)Study completedNCT07022977
What this trial is testing

MET233 in Individuals With Obesity or Overweight

Who this might be right for
Obesity and Overweight
Pfizer 144
Early research (Phase 1)Study completedNCT06564441
What this trial is testing

Test Whether BI 456906 (Survodutide) Influences the Amount of Bupropion, Caffeine and Midazolam in the Blood in People With Overweight or Obesity

Who this might be right for
OverweightObesity
Boehringer Ingelheim 34
Early research (Phase 1)Looking for participantsNCT07768813
What this trial is testing

Compare How 2 Different Formulations of Survodutide Are Taken up in the Body When Given by Injection in Healthy Men and Women With and Without Overweight or Obesity

Who this might be right for
HealthyObesity
Boehringer Ingelheim 44
Early research (Phase 1)Study completedNCT04616339
What this trial is testing

STUDY TO COMPARE PHARMACOKINETICS (PK) OF SINGLE ORAL DOSES OF DIFFERENT PF-06882961 FORMULATIONS IN PARTICIPANTS WHO ARE OVERWEIGHT OR HAVE OBESITY

Who this might be right for
Overweight and/or Obesity
Pfizer 31
Early research (Phase 1)Looking for participantsNCT07224399
What this trial is testing

Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM1812 Injection Following Single and Multiple Subcutaneous Administration in Normal to Overweight or Obese But Otherwise Healthy Men and Women

Who this might be right for
HealhtyOverweight or Obesity
BrightGene Bio-Medical Technology Co., Ltd. 60
Early research (Phase 1)Active Not RecruitingNCT06982131
What this trial is testing

A Study Investigating the Safety of RO7795081 and the Effect of RO7795081 on How the Body Processes Pitavastatin and Rosuvastatin in Otherwise Healthy Overweight or Obese Adult Participants

Who this might be right for
OverweightObesity
Hoffmann-La Roche 40
Early research (Phase 1)Study completedNCT04839393
What this trial is testing

A Drug-Drug Interaction Study Between PF-06882961 and PF-06865571 in Healthy Adult Participants and Overweight Adults or Adults With Obesity Who Are Otherwise Healthy

Who this might be right for
Healthy Volunteer
Pfizer 27
Not applicableLooking for participantsNCT07340125
What this trial is testing

Pistachio Snacking and Metabolic Flexibility

Who this might be right for
Overweight (BMI > 25)Obese But Otherwise Healthy ParticipantsOverweight or Obese+4 more
University of South Carolina 60
Testing effectiveness (Phase 2)Study completedNCT06857617
What this trial is testing

This Study Will Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of MET097 in Adult Participants With Overweight or Obesity

Who this might be right for
Obesity and Overweight
Metsera, a wholly owned subsidiary of Pfizer 120
Early research (Phase 1)Not Yet RecruitingNCT07808073
What this trial is testing

LY4329090 in Participants With Obesity or Overweight Who Are Otherwise Healthy

Who this might be right for
ObesityOverweight
Eli Lilly and Company 184
Very early researchTemporarily pausedNCT06845943
What this trial is testing

A First-in-human Study of HCR-188 in Overweight or Obese Otherwise Healthy Volunteers Without Type 2 Diabetes

Who this might be right for
Obesity and Overweight
Helicore Biopharma, Inc. 48
Next Page